Reckitt Benckiser Group plc

Reckitt Benckiser Group plc

RB.SW
Reckitt Benckiser Group plcCH flagSwiss Exchange
78.14
GBP
- -
- -
54.75BMarket Cap
Reckitt Benckiser Group plc
RB.SW
(Swiss Exchange)

Recent

price

78.14

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
9.24
10.87
11.67
13.04
13.21
12.9
12.26
12.44
13.46
16.3
17.85
18.13
19.68
18.54
20.21
- -
13.06
Revenue per Share
1.58
1.99
2.17
2.4
2.51
2.42
4.47
2.44
2.6
8.79
3.06
-5.2
1.67
-0.04
3.26
- -
2.4
Basic EPS, GAAP
1.57
2.51
1.62
2.11
2.36
2.64
2.66
2.25
2.89
3.05
2.96
1.37
4.26
1.75
2.73
- -
2.4
Free Cash Flow per Basic Share
0.62
0.91
1.07
1.2
1.26
1.38
1.37
1.3
1.47
1.61
1.68
1.73
1.75
1.75
1.75
- -
- -
Dividend per Share
24.04
25.27
26.1
27.14
27.75
28.95
30.02
30.62
31.08
38.58
40.05
33.06
33.02
31.61
33.15
- -
27.2
Book Value per Share
-4.45
-2.91
-6.54
-6.15
-7.24
-6.69
-6.13
-6.16
-7.14
-22.68
-21.97
-20.96
-19.44
-15.99
-14.99
- -
-6.17
Tangible Book Value per Share
711
713
724
728
724
718
721
713
704
702
706
709
711
714
715
- -
726
Basic Weighted Avg Shares
6,563
7,753
8,453
9,485
9,567
9,266
8,836
8,874
9,480
11,449
12,597
12,846
13,993
13,234
14,453
14,607
9,485
Sales/Revenue/Turnover
23.46
24.56
26.05
26.22
26.94
23.13
24.73
26.75
27.81
26.89
26.13
24.61
22.48
20.51
23.57
22.93
26.17
Operating Margin (%)
107
126
144
157
148
155
161
171
177
268
409
5,554
1,457
481
604
470
- -
Depreciation Expense
1,120
1,418
1,568
1,745
1,821
1,739
3,223
1,743
1,832
6,172
2,159
-3,683
1,187
-32
2,330
1,643
1,745
Net Income, GAAP
24.02
25.05
26.5
26.18
24.21
24.41
21.73
20.97
23.08
- -
19.71
- -
38.44
- -
23.18
31.36
26.18
Effective Tax Rate (%)
17.07
18.29
18.55
18.4
19.03
18.77
36.48
19.64
19.32
53.91
17.14
-28.67
8.48
-0.24
16.12
11.25
18.4
Profit Margin (%)
-2,262
-1,121
-3,099
-2,762
-3,406
-2,760
-2,129
-2,157
-1,951
-1,200
-2,717
-3,898
-1,624
-3,083
-3,056
-3,036
-2,762
Working Capital
4
4
3
3
3
598
636
671
804
11,797
9,950
8,545
9,794
7,078
7,163
6,858
3
LT Debt
3,294
4,014
5,130
5,781
5,922
6,336
6,834
6,906
8,426
13,557
14,771
9,407
9,159
7,453
9,483
8,469
5,781
Total Equity
27.88
29.16
25.46
21.92
21.67
17.21
17.97
19.6
19.89
- -
9.82
- -
9.28
- -
14.33
12.41
21.87
Return on Invested Capital (%)
6.5
7.76
7.91
8
8.12
7.53
13.64
7.33
7.7
- -
5.99
- -
3.85
- -
7.68
5.66
8.01
Return on Capital (%)
6.63
8.08
8.5
9.03
9.14
8.5
15.19
8.02
8.38
25.2
7.8
-14.25
5.06
-0.14
10.07
6.96
9.03
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Jun'11
Sep'11
Dec'11
ST Debt
2,849
- -
2,505
LT Borrowings
3
- -
3
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
728
729
729
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Jun'11
Sep'11
Dec'11
Total Current Assets
2,981
- -
2,938
Cash, Cash Equivalents & STI
581
- -
650
Accounts Receivable, Net
1,450
- -
1,247
Inventories
742
- -
758
Total Current Liabilities
6,191
- -
5,700
Payables & Accruals
- -
- -
- -
ST Debt
2,849
- -
2,505
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.97%
-8.21%
-10.69%
Free Cash Flow
18.35%
33.87%
11.92%
Net Income, GAAP
-769.98%
-1,583.25%
-29.48%
Sales/Revenue/Turnover
4.92%
3.15%
1.07%
Total Cash Common Dividend
3.17%
2.47%
7.21%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
14,453
2023
- -
- -
- -
- -
14,607
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
3.26
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
1.75
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Business
Reckitt Benckiser Group plc is a British multinational consumer goods company that manufactures and markets health, hygiene, and nutrition products worldwide. Headquartered in Slough, United Kingdom, and formed in 1999 through the merger of Reckitt & Colman plc and Benckiser N.V., the company operates in around 60 countries with products sold in nearly 200 markets; it focuses on three primary segments—Hygiene, Health, and Nutrition—through a portfolio of powerbrands including Lysol, Dettol, Harpic, Finish, Air Wick, Mortein, and Vanish disinfectants, cleaners, and air care products; Durex intimate wellness and Veet hair removal; Nurofen analgesics, Gaviscon indigestion remedies, Mucinex cough relief, Strepsils throat lozenges, and Clearasil acne treatments; plus Enfamil and Nutramigen infant nutrition formulas, Airborne immune support, Move Free joint health supplements, and Neuriva brain health products. Reckitt emphasizes innovation marketing, with over 70% of revenues from its top 19 brands, and maintains in-house manufacturing for more than 90% of its portfolio across 131 distribution centers. In a major strategic shift announced in 2024 and advancing into 2025, Reckitt agreed to divest its Essential Home business—encompassing air care, surface, pest control, and laundry products—to Advent International for up to $4.8 billion enterprise value, retaining a 30% equity stake while returning proceeds to shareholders via special dividends and a £1 billion share buyback to sharpen focus on high-growth, high-margin health and hygiene powerbrands. Recent operational expansions include a new state-of-the-art Mucinex manufacturing facility in North Carolina launching production in 2027, a Global Science and Innovation center in Shanghai for China growth, and the launch of Reckitt Catalyst in the U.S. with Serena Williams to fund 200 hygiene and healthcare entrepreneurs over five years across Africa, Asia, and Latin America.